Anastomosis devices are helpful in simplifying anastomosis procedure and minimizing surgery time.
North America accounted for the largest revenue share in 2016. Increasing prevalence of cardiovascular diseases and growing number of R&D collaborations carried out by major players in the region are projected to stimulate the growth of the region. For instance, in August 2016, Dextera Surgical Inc., entered into a joint development program with Intuitive Surgical, Inc. for developing novel surgical stapler for the latter’s da Vinci Surgical System.

The global Anastomosis Devices market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Anastomosis Devices volume and value at global level, regional level and company level. From a global perspective, this report represents overall Anastomosis Devices market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Anastomosis Devices in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Anastomosis Devices manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Medtronic
LivaNova PLC.
MAQUET Holding B.V. & KG.
Dextera Surgical
Vitalitec Internaional
Synovis Micro Companies Alliance
Ethicon US, LLC.
...

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Disposable
Reusable

Segment by Application
Cardiovascular Surgery
Gastrointestinal Surgery
Others